Dr. Reddy's on Friday said it has entered into an agreement with Novartis to acquire the cardiovascular brand Cidmus in India for Rs 456 crore ($61 million).
In the last one decade, people have witnessed the increasing sophistication of machine learning algorithms applied in daily use from internet searches, voice recognition, social network software to machine vision software in cameras, phones,
Mexican Foreign Minister Marcelo Ebrard has begun talks to receive medical technology from Indian companies to develop vaccines and cancer drugs in Mexico on Wednesday, the ministry said.
The World Health Organization’s Product Development for Vaccines Advisory Committee yesterday selected Biological E as a recipient of mRNA technology from the WHO technology transfer hub.
MTX652 has advanced through preclinical regulatory toxicology studies and is ready for a phase 1 trial.
Drug maker Lupin on Thursday told, its New Jersey facility has received 13 observations from the US drug regulator.
In the coming days curative therapies will change the face of the healthcare system.
HealthQuad, an India-focused healthcare venture capital firm, has raised $162 million in the final close of its second fund.
NTAGI will review this week’s data of Serum Institute of India’s anti-coronavirus jab Covovax to decide inclusion in the national COVID-19 vaccination programme for inoculating children aged 12 years and above, official said yesterday.
BioNTech said on Wednesday it would extend an ongoing clinical trial programme to produce new vaccines and patterns of administration for better protection against the dominant Omicron coronavirus variant.
, CDSCO.jpg)
